Browsing by Author Eslam B. Elkaeed

Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
2022Design, Synthesis and Docking Studies of New Hydrazinyl-Thiazole Derivatives as Anticancer and Antimicrobial Agents,El- naggar, Abeer ; Alaa Zidan; Eslam B. Elkaeed; Mohammed S. Taghour; Waleed A. Badawi
202Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2.El- naggar, Abeer ; Eslam B. Elkaeed; Mohamed S. Alesawy; Ahmed A. Al-Karmalawy; Hassan, A. M. A. 
2021Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.El- naggar, Abeer ; Maher A. El-Hashash; Eslam B. Elkaeed
2023New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studies,Ahmed A. Gaber; Mohamed Sobhy; Abdallah Turky; Wagdy M. Eldehna; Samiha A. El-Sebaey; Souad A. El-Metwally; El- naggar, Abeer ; Ibrahim M. Ibrahim; Eslam B. Elkaeed; Ahmed M. Metwaly; Ibrahim H. Eissa
2022Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activityNasser S. M. Ismail; Nassar, Ibrahim F. ; Asmaa A. Mandour; Mohammed T. Abdel Aal; Mahmoud A. E. Shahin; Wael A. El-Sayed; Maghawry Hegazy; Amr Mohamed Yehia; Ahmed Ismail; Mohamed Hagras; Eslam B. Elkaeed; Hanan M. Refaat
Showing results 1 to 5 of 5